Compare MYO & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYO | AEI |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.8M | 54.8M |
| IPO Year | 2017 | 2019 |
| Metric | MYO | AEI |
|---|---|---|
| Price | $1.23 | $0.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.64 | N/A |
| AVG Volume (30 Days) | ★ 247.3K | 16.3K |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,000,000,000.00 | $16,238,200.00 |
| Revenue This Year | $11.43 | N/A |
| Revenue Next Year | $12.29 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40814.79 | N/A |
| 52 Week Low | $0.61 | $0.55 |
| 52 Week High | $1.89 | $3.98 |
| Indicator | MYO | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 37.29 | 27.04 |
| Support Level | $1.18 | N/A |
| Resistance Level | $1.75 | $0.74 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 6.67 | 4.08 |
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: Real Estate, Digital Transformation Technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.